Title: Jones KL, et al. Discovery of a Novel Bromodomain and Extra Terminal Domain (BET) Protein Inhibitor, I-BET282E, Suitable for Clinical Progression. J Med Chem. 2021;64(16):12200-12227.
124924-36-3 | (3-Methyl-4-nitro-benzoylamino)-acetic acid | AA009CUF | MFCD03970403
128739-16-2 | Methylpyridin-4-ylmethylamine DiHCl | AA009DAL | MFCD03840113
14313-09-8 | 1-(3-Furyl)-1-ethanone | AA009DNZ | MFCD01568491
13369-76-1 | 1-Allyl-4-bromo-3,5-dimethyl-1h-pyrazole | AA009DSE | MFCD12027154
1259188-37-8 | Tris(2-ethylhexyl) Phosphate-d51 | AA009DWV
1219149-66-2 | N-Acetyl Sulfadiazine-d4 | AA009E3J | MFCD25974038
129970-99-6 | Perindoprilat LactaM A | AA009EBB | MFCD29472419
1279026-26-4 | BENAZEPRIL-D5 HYDROCHLORIDE | AA009EKD
1350885-65-2 | tert-Butyl 4-(5-hydroxy-4-methylpyridin-2-yl)piperazine-1-carboxylate | AA009ES3 | MFCD20501876
1233937-31-9 | Menaquinone 7-d7 | AA009F0H